Achilles, a recently launched investment trust, has emerged as a counterpoint to activist investor Saba Capital, which has been aggressively targeting underperforming firms within the investment trust sector. Both entities have identified common challenges facing these trusts, including weak performance, inactive boards, and share prices that often trade at significant discounts to net asset values.
Saba Capital, led by Boaz Weinstein, has developed a reputation for leveraging regulatory loopholes to gain control of targeted trusts without offering takeover premiums. This strategy typically involves gradually accumulating voting power through multiple requisitions until opposition diminishes, allowing Saba to effect change.
In contrast, Achilles, co-managed by Rob Naylor, emphasizes a collaborative approach. Naylor states that the trust seeks to work alongside boards and other shareholders in undervalued, well-managed companies rather than resorting to confrontational tactics. He argues that persistent monitoring and engagement are necessary to address wide discounts on trust shares.
Since its initial public offering in February 2025, Achilles' shares have delivered a modest 4% return, reflecting the nascent stage of the trust’s operations. While activist investors are often credited with improving corporate governance and unlocking value, opinions differ regarding their methods. Achilles positions itself as a constructive force within the market, whereas Saba Capital's approach has drawn criticism for its aggressive tactics.
The ongoing dynamic between these two investment trusts highlights broader debates over shareholder activism in the investment trust arena, balancing the pursuit of enhanced returns and governance improvements against the methods employed to achieve them.
